MedTrace Logo

Virtual Reality as an Adjunct to Management of Pain and Anxiety in Palliative Care

NCT04138095 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 8

Last updated 2021-03-10

No results posted yet for this study

Summary

Virtual reality has been shown to be an effective way to treat pain and anxiety in various different settings. Palliative care is an area of medicine that often deals with patients suffering from pain and anxiety. The medication used to manage these symptoms are often opioids and benzodiazepines due to their rapid onset however they do have a significant side effect burden on patients. Very few studies have looked at the effect of virtual reality in this patient population. The goal of this study is to measure if virtual reality can decrease the required amount of medication used in managing pain and anxiety in palliative care. The secondary outcome will look at perceived benefit by patients

Conditions

Interventions

DEVICE

Virtual Reality

Participants will have access to an Oculus Quest Virtual Reality Headset every second day as an alternative to opioids for pain management and benzodiazepines for anxiety management

Sponsors & Collaborators

  • Centre for Aging and Brain Health Innovation

    collaborator OTHER

  • Riverview Health Centre Foundation

    collaborator OTHER

  • Riverview Health Centre

    lead OTHER

Principal Investigators

  • Stefan Riel, MD · University of Manitoba Palliative Care Program

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-10-01
Primary Completion
2020-12-31
Completion
2021-03-30

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04138095 on ClinicalTrials.gov